Apalutamide Oral Tablet [Erleada] clinical trials

TherApeutics in Early ProState Cancer (TAPS02)

This study is looking at a new way to treat early prostate cancer. It tests a drug called apalutamide (Erleada) in men who are already under careful watch for their cancer. We want to see if this short-term treatment can help.